Teja Mahadeshwar Kapoor, MD
Overview
Teja Kapoor, MD is a graduate of New York Medical College and completed her internal medicine residency at Rutgers-Robert Wood Johnson University Hospital. She completed her Rheumatology fellowship at Columbia-NY Presbyterian, before joining full-time academic faculty. Dr. Kapoor is an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons and the Program Director for the Columbia Rheumatology Fellowship Training Program.
Dr. Kapoor has clinical and research interests in Sjogren’s Disease and Systemic Lupus Erythematosus (SLE), with years of experience in managing patients with complex multi-organ involvement of their autoimmune disease. She has lectured on SLE and Sjogren’s Disease at regional, national, and international conferences, with a multitude of book chapters and peer-reviewed article publications on the topics of autoimmune diseases. She is the recipient of the 2023-2024 Daniel V. Kimberg Memorial Junior Faculty Award for outstanding teaching of fellows, residents, and medical students. She is the Course Co-Director for Rheumatology and Autoimmunity for medical students at Columbia University Vagelos College of Physicians and Surgeons.
Areas of Expertise:
- Sjogren’s Syndrome
- Systemic Lupus Erythematosus
- Autoimmune Disease in Pregnancy
- Joint Injections
- Rheumatology
Areas of Expertise / Conditions Treated
- Ankylosing Spondylitis
- Autoimmune Disease
- Autoimmune Disease in Pregnancy
- Joint Injections
- Lupus
- Osteoarthritis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Scleroderma
- Sjogren's Syndrome
- SLE - Systemic Lupus Erythematosis
- Trigger Finger Therapy
Academic Appointments
- Assistant Professor of Medicine
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
- NewYork-Presbyterian Allen Hospital
Languages
- Hindi
- Marathi
Gender
- Female
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- NYP Employee Plan
- NY Signature
- Student Health
Affinity Health Plan
- Medicaid Managed Care
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross/Blue Shield
- EPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
Fidelis Care
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Quality Health Management
- Quality Health Management
RiverSpring
- Special Needs
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
WellCare
- Medicare Managed Care
- New Jersey Services (Medicaid Managed Care)
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- MD, New York Medical College
- Internship: Robert Wood Johnson University Hospital
- Residency: Robert Wood Johnson University Hospital
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
Committees, Societies, Councils
American College of Rheumatology
Board Certifications
- Rheumatology
- Internal Medicine
Research
Dr. Teja Kapoor’s interest in Systemic Lupus Erythematosus (SLE) began early in her career while caring for complex Lupus patients during her training at Columbia University Medical Center (CUMC). Her primary research interests in SLE include the establishment of the Columbia Lupus cohort and the use of large clinical databases to identify SLE patients treated at CUMC to evaluate their risk of infections, which have led to a publication evaluating the low prevalence of Pneumocystis carinii pneumonia. She has also presented multiple abstracts at national conferences on the risk of infections in SLE. Her overall aim in research is to find the best balance between immunosuppression while minimizing the infectious risk and complications. Her research interests also include serological biomarkers in SLE and Undifferentiated Connective Tissue Disease, and the LFA-REAL disease activity scoring instrument that allows for simple and efficient measurement of Lupus activity for use in clinical trials and clinical practices, which have led to abstract presentations at national conferences.
She has an interdisciplinary approach to managing her large cohort of patients with Sjogren’s Syndrome, working with Ophthalmology, Dental, ENT, Pulmonary, OB-GYN, and other specialists.
Selected Publications
Gartshteyn Y, Askanase A, Schmidt N, Bernstein E, Khalili L, Drolet R, Broderick R, Geraldino-Pardilla L, Kapoor T. COVID-19 and Systemic Lupus Erythematosus: a case series. The Lancet Rheumatology.2020 May 26.
Tang, W., Khalili, L., Giles, J., Gartshteyn, Y., Kapoor, T., Guo, C., Chen, T., Theodore, D., & Askanase, A. The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected Data. Rheumatology and Therapy. 2021 8(2), 681–691.
Kapoor T, Mahadeshwar P, Hui-Yuen, J, Quinnies K, Tatonetti N, Gartshteyn Y, Guo C, Geraldino-Pardilla L, Askanase A. Prevalence of Progressive Multifocal Leukoencephalopathy (PML) in adults and children with Systemic Lupus Erythematosus. Lupus Science and Medicine. 2020
Gartshteyn Y, Tamargo M, Fleischer S, Kapoor T, Li J, Askanase A, Winchester R, Geraldino-Pardilla L. Endomyocardial biopsies in the diagnosis of myocardial involvement in systemic lupus erythematosus. Lupus. 2020 Feb;29(2):199-204
Geraldino-Pardilla L, Perel-Winkler A, Miceli J, Neville K, Danias G, Nguyen S, Dervieux T, Kapoor T, Giles J, Askanase A. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort. Lupus. 2019 Jun;28(7):862-867.
Geraldino-Pardilla L, Kapoor TM, Canto I, Perez-Recio T, Then J, Tineo C, Loyo E, Askanase A. Damage accrual in systemic lupus erythematosus in Dominicans in New York City and the Dominican Republic. Lupus. 2018 Oct;27(12):1989-1995.
Askanase AD, Nguyen SC, Costenbader K, Lim SS, Kamen D, Aranow C, Grossman J, Kapoor TM, Baker-Frost D, Aberle T, Thanou-Stavraki A, Hanrahan LM, Kim M, Merrill JT. Comparison of the Lupus Foundation of America-Rapid Evaluation of Activity in Lupus to More Complex Disease Activity Instruments as Evaluated by Clinical Investigators or Real-World Clinicians. Arthritis Care Res (Hoboken). 2018 Jul;70(7):1058-1063.
Askanase AD, Nguyen SC, Costenbader K, Lim SS, Kamen D, Aranow C, Grossman J, Kapoor TM, Baker-Frost D, Aberle T, Thanou-Stavraki A, Hanrahan LM, Kim M, Merrill JT. A Rapid Evaluation of Activity of Lupus (LFA-REALTM) Correlates with More Complex Disease Activity Instruments Whether Evaluated by Clinical Investigators or Real-World Clinicians. Arthritis Care Res (Hoboken), Oct 2017.
Kapoor TM., Mahadeshwar, P., Nguyen, S., Li, J., Kapoor, S., Bathon, J., Giles, J., Askanase, A. Low prevalence of Pneumocystis pneumonia in hospitalized patients with systemic lupus erythematosus: review of a clinical data warehouse. 2017. Lupus: 961203317703494.
Kapoor T, Walker M, Sum M. Neurovascular Consequences of Systemic disease – Lupus and Primary Hyperparathyroidism, Neurovascular Neuropsychology, 2nd edition. Springer August 2020.
Kapoor T, Mahadeshwar P, Systemic Lupus Erythematosus, Absolute Rheumatology Board Review, 1st edition 2019. Springer; October 2019.
Kapoor TM, Bathon J. Renal Manifestations of Rheumatoid Arthritis. Rheumatic Disease Clinics of North America. 2018 Nov;44(4):571-584.
Wang S, Tanner S, Kapoor T, Perez T, D'Agati VD, Askanase A, Winchester R, Geraldino-Pardilla L. A Higher Activity Index at Initial Renal Biopsy Is Associated with Rapid Progression to Renal Failure in Patients with Refractory Lupus Nephritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10).
Danias, G, Kim Y, Marone A, Neville K, Frantz A, Kapoor T, Geraldino-Pardilla, Kymissis I, Hielscher A, Askanase A. Diagnosing SLE arthritis with Dynamic Optical Spectroscopy [abstract]. Arthritis Rheumatology. 2018; 70 (suppl 10).
Epstein, H, Pena DP, Di Cocco B, Kapoor T, Askanase A. The Role of Hydroxychloroquine in the Treatment of Undifferentiated Connective Tissue Disease [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10).
Gartshteyn Y, Hui-Yuen J, Okado M, Kapoor T, Dervieux T, Askanase A. Cell-Bound Complement Activation Products as Markers of Disease Flares in Childhood Onset Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10)
Kapoor T, Mahadeshwar P, Bhandari B, Li J, Bathon J, Nguyen S, Askanase AD.Herpetic Viruses in Lupus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10).
Neville K, Miceli J, Li J, Nguyen S, Kapoor T, Askanase A. Estimated Cost of SLE Hospitalizations [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10).
Mahadeshwar T, Kim H, Tikotekar A, Parikh A. Timing of renal replacement therapy: is it when or how much? Crit Care. 2013; 17(4): 445
For a complete list of publications, please visit PubMed.gov